Total Count 119

JAMJOOM PHARMA - Latest News

Jamjoom Pharma reviews 2025-2027 guidance

Argaam Special 27/07/2025

Q2 2025 earnings preview: AlJazira Capital

Argaam Special 06/07/2025

Ranked: Tadawul's 50 most profitable companies in Q1 2025

Argaam Special 26/05/2025

How did analysts view Jamjoom Pharma Q1 2025 financials?

Argaam Special 14/05/2025

Ubhar Capital: Jamjoom Pharma Q1 profit above estimates, TP unchanged

Argaam 05/05/2025

Jamjoom Pharma revises guidance for next 3 years 

Argaam Special 30/04/2025

AlJazira Capital initiates coverage on Saudi pharmaceuticals sector, sets ratings

Argaam 29/04/2025

Highest-paid executives, board members of Saudi-listed firms in 2024

Argaam Special 21/04/2025

Al Rajhi Capital sets Jamjoom Pharma rating, TP

Argaam 08/03/2025

Ubhar Capital initiates coverage of Jamjoom Pharma, sets rating, TP

Argaam 25/01/2025

SNB Capital forecasts Tadawul earnings to rise 8% in 2025

Argaam 01/01/2025

Analyst ratings, average TP for Jamjoom Pharma post-Q3 2024

Argaam Special 23/12/2024

Jamjoom Pharma maintains 2024 guidance

Argaam Special 27/10/2024

What do analysts expect from Jamjoom Pharma's Q3 2024 results?

Argaam Special 24/10/2024

GIB Capital's forecast on Q3 2024 earnings

Argaam Special 10/10/2024

Key events forecast to impact Saudi-listed firms’ earnings in Q3 2024

Argaam Special 06/10/2024

SNB Capital initiates coverage on Jamjoom Pharma, sets TP

Argaam 15/09/2024

How analysts rated Jamjoom Pharma after Q2 results?

Argaam Special 11/09/2024

Saudi pharmaceuticals sector seen to grow: Al Rajhi Capital

ِArgaam 09/09/2024

United Securities says Jamjoom Pharma’s net profit beats expectations

Argaam 12/08/2024

Analyst forecasts on Jamjoom Pharma Q2 2024 profit

Argaam Special 05/08/2024

Key events likely to impact Saudi-listed firms’ earnings in Q2 2024

Argaam Special 04/07/2024

United Securities sets rating, TP for Jamjoom Pharma

Argaam 19/05/2024

Senior execs of Aramco, SNB, eXtra, stc highest paid in 2023

Argaam Special 21/04/2024

Jamjoom Pharma's 2023 net profit exceeds estimates: United Securities

Argaam 27/03/2024

Jamjoom Pharma seen to post profit growth in Q4 2023

Argaam Special 20/02/2024

GIB Capital previews Q4 2023 earnings

Argaam Special 10/01/2024

How did analysts view TASI performance, top picks for 2024?

Argaam Special 09/01/2024

Al Rajhi Capital expects TASI to hit 12,647 pts, names top picks

Argaam 07/01/2024

How did analysts view Jamjoom Pharma’s Q3 financials?

Argaam Special 05/12/2023

GIB Capital sets rating for Jamjoom Pharma

Argaam 03/12/2023

Al Rajhi Capital says Saudi pharmaceuticals sector poised for growth; sets recommendations, TP

Argaam 23/11/2023

Jamjoom Pharma revises up 2023 guidance

Argaam Special 10/08/2023